Sooil Development participated in the 54th EASD2018 (European Association for the Study of Diabetes) held in Berlin, Germany from October 1st to 5^th. Sooil Development showed the superiority of Dana insulin pump, the most effective treatment for diabetes. 

Participating EASD2018 is the fourth overseas exhibition this year. Sooil Development informs the superior technology of medical device and the high level technology of Dana insulin pump. Dana Insulin Pump is a diabetes care device that has been approved by the FDA. 

Dana is expanding its awareness and solidifying its position in the global market. Sooil development is currently selling in 66 countries including the United States, Germany, and China.

Especially, AnyDana application, which plays an important role in improving the quality of life of diabetic patients has updated. SOOIL announced 'Any Dana-I' which can be used in IOS, and it received great response from the medical staff and users.

Sooil said, "The world-renowned European Diabetes Association was a good opportunity to inform the world's medical staff about our superior technology." It is expected to be a good opportunity to further expand Dana's insulin pumps into the global market.

The annual EASD is a world-renowned diabetes conference attended by more than 18,000 diabetes-related physicians and health professionals from more than 130 countries and is held annually in major European cities between September and October.